ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ICUI ICU Medical Inc

94.84
0.31 (0.33%)
After Hours
Last Updated: 19:18:02
Delayed by 15 minutes

Period:

Draw Mode:

Volume 81,315
Bid Price 94.45
Ask Price 95.35
News -
Day High 96.59

Low
78.28

52 Week Range

High
212.43

Day Low 94.19
Company Name Stock Ticker Symbol Market Type
ICU Medical Inc ICUI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.31 0.33% 94.84 19:18:02
Open Price Low Price High Price Close Price Prev Close
94.19 94.19 96.59 94.84 94.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,426 81,315 $ 95.49 $ 7,764,879 - 78.28 - 212.43
Last Trade Time Type Quantity Stock Price Currency
16:01:11 16 $ 94.84 USD

ICU Medical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.29B 24.14M - 2.28B -29.66M -1.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ICU Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ICUI Message Board. Create One! See More Posts on ICUI Message Board See More Message Board Posts

Historical ICUI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week97.1399.530193.35596.25158,780-2.29-2.36%
1 Month107.72108.4393.355100.10203,714-12.88-11.96%
3 Months91.49123.4686.80101.70252,7273.353.66%
6 Months103.71123.4678.2894.72328,213-8.87-8.55%
1 Year180.12212.4378.28117.90257,501-85.28-47.35%
3 Years211.62282.0078.28162.19205,113-116.78-55.18%
5 Years226.27282.0078.28173.40188,683-131.43-58.09%

ICU Medical Description

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU's acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.

Your Recent History

Delayed Upgrade Clock